Anjali Mishra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anjali Mishra has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
- Gaurav Agarwal
Department of Endocrine Surgery Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow India
24 shared publications Amit Agarwal
Department of Endocrine Surgery Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow India
22 shared publicationsSaroj Kanta Mishra
Department of Endocrine Surgery Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow India
20 shared publicationsGyan Chand
Department of Endocrine Surgery Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow India
17 shared publicationsGaurav Agarwal
14 shared publications- Saroj Kanta Mishra
Department of Endocrine Surgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
12 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Taylor & Francis in BioTechniques
- Vol. 78 (1-12) , 371-382
A simple prestaining protocol to enhance visualization and embedding of 3D breast cancer organoids for downstream histological analysis
1. Organoids are three-dimensional multicellular in vitro systems that reproduce key structural and functional properties of their tissue of origin. In breast cancer research, patient-derived organ...
- 4 November 2026
- Published by Taylor & Francis in BioTechniques
- Vol. 78 (1-12) , 371-382
Open AccessA simple prestaining protocol to enhance visualization and embedding of 3D breast cancer organoids for downstream histological analysis
1. Organoids are three-dimensional multicellular in vitro systems that reproduce key structural and functional properties of their tissue of origin. In breast cancer research, patient-derived organ...
- 25 September 2026
- Published by Wiley in World Journal of Surgery
- Vol. 50 (11) , 3275-3284
Factors Predicting the Need for Intravenous Calcium Infusion in Patients With Advanced Primary Hyperparathyroidism Undergoing Parathyroidectomy
Background: A substantial proportion of patients with primary hyperparathyroidism (PHPT) presenting with advanced skeletal manifestations develop “hungry bone syndrome” following parathyroidectomy (PTx). This study aimed to identify predictors of the need for intravenous (IV) calcium (Ca) infusion in the postoperative period. Methods: This retrospective study (January 2000–December 2024) included 554 symptomatic PHPT patients undergoing PTx. Patients were divided into two groups: Group 1 ( n = 96), who required IV Ca infusion, and Group 2 ( n = 458), who did not. Clinical, biochemical, and operative parameters were compared. Results: Overall, 17% of patients required IV Ca infusion. On univariate analysis, Group 1 patients were significantly young ( p < 0.001) and had a higher incidence of bed‐ridden status ( p = 0.001), bony symptoms ( p < 0.001), skeletal fractures ( p < 0.001), and osteoporosis ( p = 0.025). Serum parathyroid hormone (PTH; p = 0.001) and alkaline phosphatase levels ( p < 0.001) were significantly higher, whereas bone mineral density at the spine ( p = 0.001), hip ( p < 0.001), and distal radius ( p = 0.001) was significantly lower. Bilateral neck exploration (BNE; p = 0.047) as well as resected gland size ( p < 0.001) and weight ( p = 0.007) were higher in Group 1. On multivariable analysis, age ( p = 0.006), bony symptoms ( p = 0.016), PTH ( p = 0.041), BNE ( p = 0.014), and parathyroid weight ( p = 0.005) remained significant predictors. Conclusions: Young age, bony symptoms, BNE, and higher PTH levels and gland weight are significant predictors of the need for IV Ca after PTx in advanced PHPT. However, most patients can be effectively managed with oral Ca and vitamin D supplementation.
- 25 September 2026
- Published by Wiley in World Journal of Surgery
- Vol. 50 (11) , 3275-3284
Factors Predicting the Need for Intravenous Calcium Infusion in Patients With Advanced Primary Hyperparathyroidism Undergoing Parathyroidectomy
Background: A substantial proportion of patients with primary hyperparathyroidism (PHPT) presenting with advanced skeletal manifestations develop “hungry bone syndrome” following parathyroidectomy (PTx). This study aimed to identify predictors of the need for intravenous (IV) calcium (Ca) infusion in the postoperative period. Methods: This retrospective study (January 2000–December 2024) included 554 symptomatic PHPT patients undergoing PTx. Patients were divided into two groups: Group 1 ( n = 96), who required IV Ca infusion, and Group 2 ( n = 458), who did not. Clinical, biochemical, and operative parameters were compared. Results: Overall, 17% of patients required IV Ca infusion. On univariate analysis, Group 1 patients were significantly young ( p < 0.001) and had a higher incidence of bed‐ridden status ( p = 0.001), bony symptoms ( p < 0.001), skeletal fractures ( p < 0.001), and osteoporosis ( p = 0.025). Serum parathyroid hormone (PTH; p = 0.001) and alkaline phosphatase levels ( p < 0.001) were significantly higher, whereas bone mineral density at the spine ( p = 0.001), hip ( p < 0.001), and distal radius ( p = 0.001) was significantly lower. Bilateral neck exploration (BNE; p = 0.047) as well as resected gland size ( p < 0.001) and weight ( p = 0.007) were higher in Group 1. On multivariable analysis, age ( p = 0.006), bony symptoms ( p = 0.016), PTH ( p = 0.041), BNE ( p = 0.014), and parathyroid weight ( p = 0.005) remained significant predictors. Conclusions: Young age, bony symptoms, BNE, and higher PTH levels and gland weight are significant predictors of the need for IV Ca after PTx in advanced PHPT. However, most patients can be effectively managed with oral Ca and vitamin D supplementation.
- 4 August 2026
- Published by Wiley in Clinical Endocrinology
- Vol. 105 (4) , 395-407
Parathyroid Carcinoma Revisited: Clinical and Pathological Insights From Two Decades of Experience
Background: Parathyroid carcinoma is a rare endocrine malignancy (< 1% of primary hyperparathyroidism and 0.005% of all cancers) that often mimics a benign adenoma, leading to diagnosis only after surgery, unless invasion or metastasis is present. Objective: To identify distinguishing clinical, biochemical and pathological features of parathyroid carcinoma in comparison with primary parathyroid adenoma and atypical parathyroid tumor and to determine its perioperative predictors. Methods: A retrospective analysis compared 16 histopathologically confirmed parathyroid carcinoma cases with 378 primary parathyroid adenoma and 11 atypical parathyroid tumors, evaluating and contrasting their clinical and laboratory features. Results: No significant differences in age or gender were observed across groups. Parathyroid carcinoma was significantly associated with hoarseness, hypercalcaemic crisis, palpable neck mass (all p < 0.001), pancreatitis, and concomitant bone/kidney involvement (both p < 0.05). Ridge‐penalized logistic regression identified hoarseness, palpable neck mass and an involved parathyroid gland weight ≥ 3 grams (g) as significant perioperative predictors of parathyroid carcinoma while adenoma diameter, serum calcium levels and intact parathyroid hormone (iPTH) were not statistically significant. ROC analysis showed parathyroid adenoma weight of ≥ 7.5 g had the highest diagnostic accuracy (75% sensitivity, 86% specificity), whereas serum calcium and iPTH exhibited only moderate diagnostic performance. Recurrence was observed in 31% of cases. Conclusion: Parathyroid carcinoma exhibits more severe clinical and biochemical features and greater gland weight than benign lesions. The high recurrence rate necessitates rigorous long‐term surveillance. While offering a framework for preoperative risk stratification, these retrospective findings require prospective validation in larger cohorts.
- 4 August 2026
- Published by Wiley in Clinical Endocrinology
- Vol. 105 (4) , 395-407
Parathyroid Carcinoma Revisited: Clinical and Pathological Insights From Two Decades of Experience
Background: Parathyroid carcinoma is a rare endocrine malignancy (< 1% of primary hyperparathyroidism and 0.005% of all cancers) that often mimics a benign adenoma, leading to diagnosis only after surgery, unless invasion or metastasis is present. Objective: To identify distinguishing clinical, biochemical and pathological features of parathyroid carcinoma in comparison with primary parathyroid adenoma and atypical parathyroid tumor and to determine its perioperative predictors. Methods: A retrospective analysis compared 16 histopathologically confirmed parathyroid carcinoma cases with 378 primary parathyroid adenoma and 11 atypical parathyroid tumors, evaluating and contrasting their clinical and laboratory features. Results: No significant differences in age or gender were observed across groups. Parathyroid carcinoma was significantly associated with hoarseness, hypercalcaemic crisis, palpable neck mass (all p < 0.001), pancreatitis, and concomitant bone/kidney involvement (both p < 0.05). Ridge‐penalized logistic regression identified hoarseness, palpable neck mass and an involved parathyroid gland weight ≥ 3 grams (g) as significant perioperative predictors of parathyroid carcinoma while adenoma diameter, serum calcium levels and intact parathyroid hormone (iPTH) were not statistically significant. ROC analysis showed parathyroid adenoma weight of ≥ 7.5 g had the highest diagnostic accuracy (75% sensitivity, 86% specificity), whereas serum calcium and iPTH exhibited only moderate diagnostic performance. Recurrence was observed in 31% of cases. Conclusion: Parathyroid carcinoma exhibits more severe clinical and biochemical features and greater gland weight than benign lesions. The high recurrence rate necessitates rigorous long‐term surveillance. While offering a framework for preoperative risk stratification, these retrospective findings require prospective validation in larger cohorts.
- 7 December 2025
- Published by Wiley in World Journal of Surgery
- Vol. 50 (2) , 385-392
BRIDGEing the Gap: Impact of a Short Virtual Course on Delivering Global‐Standard Breast Cancer Care in Low‐Resource Settings
Background: Access to guideline‐concordant global‐standard breast cancer care remains limited in many low‐ and middle‐income countries (LMICs), where high‐cost technologies for diagnostics, surgical diagnosis and treatment (such as radioisotope mapping, ICG fluorescence, and intraoperative margin assessment) are not widely available. The BRIDGE Course (Breast Surgery Resource Integration & Development for Global Excellence) was designed as a short, virtual educational program to educate and update surgeons with validated, low‐cost techniques that ensure oncologic safety while addressing resource constraints. Methods: A 7‐h online course was designed and conducted in September 2025 with participation from international and national faculty. Content emphasized pragmatic adaptations of global guidelines, including triple assessment, surgical decision‐making for mastectomy versus breast conservation, sentinel lymph node biopsy (SLNB) using methylene blue and fluorescein torch, and low‐cost oncoplastic approaches. Pre‐ and post‐course surveys assessed baseline practice, perceived barriers, satisfaction, confidence, and intent to implement. Descriptive statistics were analyzed. Results: Seventy‐five participants completed the pre‐course survey and 66 completed the post‐course survey. At baseline, mastectomy was the most common primary operation (30.7%), whereas only 20% predominantly performed breast‐conserving surgery; SLNB was mainly performed using methylene blue (68.5%). Reported barriers included lack of resources, training gaps, and patient mindset. Post‐course, ≥ 85% of participants reported improved confidence across all domains: triple assessment (83% strongly agreed), mastectomy versus BCS decision‐making (74%), SLNB with low‐cost tracers (66%), and complication management (60%). Implementation intent was high, with nearly all (96%) planning to adopt at least one new technique and all intending to share knowledge with colleagues or trainees. Conclusion: The BRIDGE Course successfully enhanced knowledge and confidence in resource‐adapted breast cancer surgery, with strong intent to implement and improve practices. Such short, focused virtual programs may serve as a scalable model for narrowing disparities in breast cancer care across LMICs.
- 7 December 2025
- Published by Wiley in World Journal of Surgery
- Vol. 50 (2) , 385-392
BRIDGEing the Gap: Impact of a Short Virtual Course on Delivering Global‐Standard Breast Cancer Care in Low‐Resource Settings
Background: Access to guideline‐concordant global‐standard breast cancer care remains limited in many low‐ and middle‐income countries (LMICs), where high‐cost technologies for diagnostics, surgical diagnosis and treatment (such as radioisotope mapping, ICG fluorescence, and intraoperative margin assessment) are not widely available. The BRIDGE Course (Breast Surgery Resource Integration & Development for Global Excellence) was designed as a short, virtual educational program to educate and update surgeons with validated, low‐cost techniques that ensure oncologic safety while addressing resource constraints. Methods: A 7‐h online course was designed and conducted in September 2025 with participation from international and national faculty. Content emphasized pragmatic adaptations of global guidelines, including triple assessment, surgical decision‐making for mastectomy versus breast conservation, sentinel lymph node biopsy (SLNB) using methylene blue and fluorescein torch, and low‐cost oncoplastic approaches. Pre‐ and post‐course surveys assessed baseline practice, perceived barriers, satisfaction, confidence, and intent to implement. Descriptive statistics were analyzed. Results: Seventy‐five participants completed the pre‐course survey and 66 completed the post‐course survey. At baseline, mastectomy was the most common primary operation (30.7%), whereas only 20% predominantly performed breast‐conserving surgery; SLNB was mainly performed using methylene blue (68.5%). Reported barriers included lack of resources, training gaps, and patient mindset. Post‐course, ≥ 85% of participants reported improved confidence across all domains: triple assessment (83% strongly agreed), mastectomy versus BCS decision‐making (74%), SLNB with low‐cost tracers (66%), and complication management (60%). Implementation intent was high, with nearly all (96%) planning to adopt at least one new technique and all intending to share knowledge with colleagues or trainees. Conclusion: The BRIDGE Course successfully enhanced knowledge and confidence in resource‐adapted breast cancer surgery, with strong intent to implement and improve practices. Such short, focused virtual programs may serve as a scalable model for narrowing disparities in breast cancer care across LMICs.
- 30 May 2025
- Published by Wiley in World Journal of Surgery
- Vol. 49 (7) , 1820-1827
ProInflammatory Cytokines in Patients With Thyroid Nodules Before, During, and After Thyroidectomy in a Tertiary Referral Center
Background: Thyroid nodules are epidemic in certain countries. Advancements in imaging technology and increased healthcare screening have led to a notable rise in their detection. This surge in detection has also sparked a renewed focus on understanding their pathophysiology. Limited research exists regarding involvement of proinflammatory cytokines in thyroid disorders. We studied the presence of these proinflammatory cytokines in preoperative serum samples from the tissue of interest (colloid) retrieved during surgery, and postoperative serum samples.Materials and Methods: We performed a prospective study including patients having solitary thyroid nodule (colloid goiter) undergoing surgery. A total of 3 mL each of preoperative serum sample, aspirated colloid from thyroid specimen, and postoperative serum sample 4 weeks after surgery were collected. The quantification of supernatant cytokines (IL‐1, IL‐4, IL‐6, IL‐10, IL‐12, IL‐17A, IFN‐γ, TNF‐α, and TGF‐β) was done by ELISA. Standard protocols for ELISA were followed, and all assays were performed in duplicate to ensure accuracy.Results: The study included 40 patients with a median age of 32.5 years (27–48.5 years). The majority of our participants were female, reflecting the higher prevalence of thyroid nodules in women. On analyzing the levels of proinflammatory cytokines, significant differences were seen between the preoperative serum sample, colloid sample, and postoperative serum sample. Colloid had considerably higher levels of proinflammatory cytokines (IL‐1, IL‐4, IL‐6, IL‐10, IL‐12, IL‐17A, IFN‐γ, TNF‐α, and TGF‐β) when compared to both pre‐ and postoperative serum samples (p < 0.05).Conclusion: Markedly elevated levels of proinflammatory cytokines seen in colloid obtained during surgery compared to both the pre‐ and postoperative serum samples suggest that the inflammatory milieu of thyroid tissue is different to that of the systemic circulation. These findings provide a foundation for further research into the inflammatory mechanisms.Research Registry Registration: No: 8638 dated January 22, 2023
- 30 May 2025
- Published by Wiley in World Journal of Surgery
- Vol. 49 (7) , 1820-1827
ProInflammatory Cytokines in Patients With Thyroid Nodules Before, During, and After Thyroidectomy in a Tertiary Referral Center
Background: Thyroid nodules are epidemic in certain countries. Advancements in imaging technology and increased healthcare screening have led to a notable rise in their detection. This surge in detection has also sparked a renewed focus on understanding their pathophysiology. Limited research exists regarding involvement of proinflammatory cytokines in thyroid disorders. We studied the presence of these proinflammatory cytokines in preoperative serum samples from the tissue of interest (colloid) retrieved during surgery, and postoperative serum samples.Materials and Methods: We performed a prospective study including patients having solitary thyroid nodule (colloid goiter) undergoing surgery. A total of 3 mL each of preoperative serum sample, aspirated colloid from thyroid specimen, and postoperative serum sample 4 weeks after surgery were collected. The quantification of supernatant cytokines (IL‐1, IL‐4, IL‐6, IL‐10, IL‐12, IL‐17A, IFN‐γ, TNF‐α, and TGF‐β) was done by ELISA. Standard protocols for ELISA were followed, and all assays were performed in duplicate to ensure accuracy.Results: The study included 40 patients with a median age of 32.5 years (27–48.5 years). The majority of our participants were female, reflecting the higher prevalence of thyroid nodules in women. On analyzing the levels of proinflammatory cytokines, significant differences were seen between the preoperative serum sample, colloid sample, and postoperative serum sample. Colloid had considerably higher levels of proinflammatory cytokines (IL‐1, IL‐4, IL‐6, IL‐10, IL‐12, IL‐17A, IFN‐γ, TNF‐α, and TGF‐β) when compared to both pre‐ and postoperative serum samples (p < 0.05).Conclusion: Markedly elevated levels of proinflammatory cytokines seen in colloid obtained during surgery compared to both the pre‐ and postoperative serum samples suggest that the inflammatory milieu of thyroid tissue is different to that of the systemic circulation. These findings provide a foundation for further research into the inflammatory mechanisms.Research Registry Registration: No: 8638 dated January 22, 2023
- 19 August 2024
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 87 (2) , 289-293
Trends and Reasons of Referral of Benign Breast Disease Patients in a Tertiary Hospital in India
- 19 August 2024
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 87 (2) , 289-293
Trends and Reasons of Referral of Benign Breast Disease Patients in a Tertiary Hospital in India
- Open Access
- 1 August 2024
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 86 (S1) , 1
Editorial for Special Edition on Endocrine Surgery
- 1 August 2024
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 86 (S1) , 1
Open AccessEditorial for Special Edition on Endocrine Surgery
- 1 February 2024
- Published by Wiley in World Journal of Surgery
- Vol. 48 (3) , 729-738
Clinico‐pathologic profile and outcomes of pediatric endocrine patients managed by endocrine surgeons: Experience over three decades in a tertiary center in India
Background: Pediatric endocrine disorders requiring surgical intervention are rare and so are experienced surgeons dealing with these. The aim of the current study was to investigate disease profile and perioperative outcome of pediatric patients with surgical endocrine disorders in an endocrine surgery unit.Methods: This retrospective study (Sep 1989–Aug 2019) consisted of pediatric endocrine surgery patients (F = 1:1.6). Thyroid disorders were most prevalent (59.8%), followed by adrenal (28.2%), parathyroid (10.4%), and pancreas (1.5%). Incidence of benign, malignant, and congenital/developmental disorders were 65.4, 28.1 and 8.3, respectively. Familial association was observed in 8.9% children, which is highest among pheochromocytoma patients. Overall, 201 thyroidectomies + associated procedures, 35 parathyroidectomies, 96 adrenal and paraganglioma resections, and 5 pancreatic procedures were performed. Median hospital stay was 5.6 ± 4.1 days. The number of cases increased significantly over 3 decades. Clinical profile and outcome did not vary except for significant decrease in incidence of malignant pathology (p = 0.04) and increase in VHL cases (p = 0.04) in the last decade though overall increase in familial cases was nonsignificant (p = 0.11). No perioperative mortality was observed except for 3% after adrenalectomy.Conclusion: A team of dedicated endocrine surgeons and pediatric endocrinologists is effective in management of pediatric endocrine surgery.
- 1 February 2024
- Published by Wiley in World Journal of Surgery
- Vol. 48 (3) , 729-738
Clinico‐pathologic profile and outcomes of pediatric endocrine patients managed by endocrine surgeons: Experience over three decades in a tertiary center in India
Background: Pediatric endocrine disorders requiring surgical intervention are rare and so are experienced surgeons dealing with these. The aim of the current study was to investigate disease profile and perioperative outcome of pediatric patients with surgical endocrine disorders in an endocrine surgery unit.Methods: This retrospective study (Sep 1989–Aug 2019) consisted of pediatric endocrine surgery patients (F = 1:1.6). Thyroid disorders were most prevalent (59.8%), followed by adrenal (28.2%), parathyroid (10.4%), and pancreas (1.5%). Incidence of benign, malignant, and congenital/developmental disorders were 65.4, 28.1 and 8.3, respectively. Familial association was observed in 8.9% children, which is highest among pheochromocytoma patients. Overall, 201 thyroidectomies + associated procedures, 35 parathyroidectomies, 96 adrenal and paraganglioma resections, and 5 pancreatic procedures were performed. Median hospital stay was 5.6 ± 4.1 days. The number of cases increased significantly over 3 decades. Clinical profile and outcome did not vary except for significant decrease in incidence of malignant pathology (p = 0.04) and increase in VHL cases (p = 0.04) in the last decade though overall increase in familial cases was nonsignificant (p = 0.11). No perioperative mortality was observed except for 3% after adrenalectomy.Conclusion: A team of dedicated endocrine surgeons and pediatric endocrinologists is effective in management of pediatric endocrine surgery.
- 15 January 2024
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 15 (2) , 250-257
Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC)
Background Molecular sub-characterization of triple-negative breast cancer (TNBC) has great therapeutic and possibly prognostic implications. The primary aim of this study was to investigate the incidence of luminal androgen receptor (LAR) subtype of TNBC and secondary aims were sub-categorization and clinico-pathologic correlation of LAR breast cancers. Retrospective study (January 2008 and 31st of December 2018) consisting of 157 TNBC patients. Androgen receptor (AR) expression was measured by immunohistochemical analysis. One percent cutoff was set as a positive expression. Sub-categorization was done on the basis of EGFR (> 15% of tumor cells) and Ki-67 expression (low- < 11%, intermediate- 11–20%, and high- > 21%). AR expression was correlated with various clinico-pathologic features and outcomes of the patients. The incidence of AR expression in TNBC was 24.8%. Considering different thresholds of > 5%, > 10%, and > 20% immunostaining, the incidence of AR positivity was 18.4, 15.2, and 11.5% respectively. The incidence of Ki-67 (p = 0.89) and EGFR (p = 0.643) expression did not differ significantly in AR-positive and -negative TNBC. Based on EGFR expression 19, 67 and 14% patients were categorized as low, intermediate, and high risk respectively. Low-risk (p ≤ 0.001) and low-grade (p = 0.014) tumors were more likely to have > 10% AR expression. Clinico-pathological profile, response to neoadjuvant chemotherapy, disease-free survival (p = 0.458), and overall survival (p = 0.806) did not significantly differ between AR expressing and negative TNBC. On multivariate analysis, only tumor staging was a significant predictor of survival (p = 0.012) and AR expression of > 10% revealed a trend towards improved survival (p = 0.07). When considering only AR-positive TNBC, AR expression of > 10% (p = 0.038), distant metastases (p = 0.003), and EGFR status (p = 0.024) were significantly associated with survival. AR expression does not seem to very strongly correlate with prognosis in TNBC and further studies could focus more on its predictive role in deciding anti-androgen therapy.
- 15 January 2024
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 15 (2) , 250-257
Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC)
Background Molecular sub-characterization of triple-negative breast cancer (TNBC) has great therapeutic and possibly prognostic implications. The primary aim of this study was to investigate the incidence of luminal androgen receptor (LAR) subtype of TNBC and secondary aims were sub-categorization and clinico-pathologic correlation of LAR breast cancers. Retrospective study (January 2008 and 31st of December 2018) consisting of 157 TNBC patients. Androgen receptor (AR) expression was measured by immunohistochemical analysis. One percent cutoff was set as a positive expression. Sub-categorization was done on the basis of EGFR (> 15% of tumor cells) and Ki-67 expression (low- < 11%, intermediate- 11–20%, and high- > 21%). AR expression was correlated with various clinico-pathologic features and outcomes of the patients. The incidence of AR expression in TNBC was 24.8%. Considering different thresholds of > 5%, > 10%, and > 20% immunostaining, the incidence of AR positivity was 18.4, 15.2, and 11.5% respectively. The incidence of Ki-67 (p = 0.89) and EGFR (p = 0.643) expression did not differ significantly in AR-positive and -negative TNBC. Based on EGFR expression 19, 67 and 14% patients were categorized as low, intermediate, and high risk respectively. Low-risk (p ≤ 0.001) and low-grade (p = 0.014) tumors were more likely to have > 10% AR expression. Clinico-pathological profile, response to neoadjuvant chemotherapy, disease-free survival (p = 0.458), and overall survival (p = 0.806) did not significantly differ between AR expressing and negative TNBC. On multivariate analysis, only tumor staging was a significant predictor of survival (p = 0.012) and AR expression of > 10% revealed a trend towards improved survival (p = 0.07). When considering only AR-positive TNBC, AR expression of > 10% (p = 0.038), distant metastases (p = 0.003), and EGFR status (p = 0.024) were significantly associated with survival. AR expression does not seem to very strongly correlate with prognosis in TNBC and further studies could focus more on its predictive role in deciding anti-androgen therapy.